Results 31 to 40 of about 232,776 (304)

A rare cause of atraumatic fractures: case series of four patients with tumor-induced osteomalacia

open access: yesClinical Diabetes and Endocrinology, 2020
Background Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome that presents with hypophosphatemia, bone pain, muscle weakness and fractures.
Debbie W. Chen   +4 more
doaj   +1 more source

Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion [PDF]

open access: yesJornal Brasileiro de Pneumologia, 2023
Objective: Lymphangioleiomyomatosis (LAM) is a rare, destructive disease of the lungs with a limited number of determinants of disease activity, which are a critical need for clinical trials.
Anthony J Esposito   +9 more
doaj   +1 more source

FGF-23 (Fibroblast Growth Factor-23) and Cardiorenal Interactions

open access: yesCirculation: Heart Failure, 2021
Background: Animal models implicate FGF-23 (fibroblast growth factor-23) as a direct contributor to adverse cardiorenal interactions such as sodium avidity, diuretic resistance, and neurohormonal activation, but this has not been conclusively demonstrated in humans.
Juan B. Ivey-Miranda   +15 more
openaire   +4 more sources

Fibroblast Growth Factor-23 and a Vegetarian Diet [PDF]

open access: yesJournal of Renal Nutrition, 2020
Sparse data exist on population distributions of serum fibroblast growth factor-23 (FGF23) levels from developing, middle-income economies. FGF23 levels may differ substantially across regions based on differences in diet and urbanization. In a population-based study from North India, we tested the hypothesis that urinary phosphate excretion and FGF23 ...
Shuchi Anand   +5 more
openaire   +2 more sources

Dietary vitamin D3 deprivation suppresses fibroblast growth factor 23 signals by reducing serum phosphorus levels in laying hens

open access: yesAnimal Nutrition, 2022
The present study was carried out to evaluate the effect of dietary supplemental vitamin D3 on fibroblast growth factor 23 (FGF23) signals as well as phosphorus homeostasis and metabolism in laying hens.
Jiakun Yan   +8 more
doaj   +1 more source

Comparison of fibroblast-growth factor-23 level between males and female’s broiler using HPLC technique [PDF]

open access: yesIraqi Journal of Veterinary Sciences, 2023
Animal public health is crucial concern when considering the role of fibroblast growth factor-23 (FGF-23) in regulating phosphate metabolism. FGF-23 has been associated with to various diseases in animal, such as chronic kidney and cardiovascular disease,
Soulaf J. Kakel, Ayman M. Albanna
doaj   +1 more source

Fibroblast growth factor 23 and bone mineralisation [PDF]

open access: yesInternational Journal of Oral Science, 2015
Fibroblast growth factor 23 (FGF23) is a hormone that is mainly secreted by osteocytes and osteoblasts in bone. The critical role of FGF23 in mineral ion homeostasis was first identified in human genetic and acquired rachitic diseases and has been further characterised in animal models.
Guo, Yu-Chen, Yuan, Quan
openaire   +2 more sources

Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension

open access: yesPulmonary Circulation, 2019
Metabolic abnormalities are proposed to contribute to pulmonary arterial as well as right ventricular remodelling in pulmonary arterial hypertension. Among the proposed abnormalities are altered glucose and lipid processing, mitochondrial malfunction ...
Habib Bouzina   +2 more
doaj   +1 more source

Fibroblast growth factor 23 levels before and after renal transplantation

open access: yesThe Egyptian Journal of Internal Medicine, 2016
Background Fibroblast growth factor 23 (FGF23), a novel bone-derived hormone that inhibits phosphate reabsorption and calcitriol production by the kidney, has uncovered primary regulatory pathways and new systems biology governing bone mineralization ...
Mohamed M El-khatib   +4 more
doaj   +1 more source

Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease

open access: yesRenal Failure, 2023
Introduction It has been observed that intravenous iron administration may suppress endogenous production of erythropoietin (EPO). We postulate that this effect may be mediated by increased FGF-23 secretion.Aim of the study To evaluate the short-term ...
Katarzyna Muras-Szwedziak   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy